MGE Energy Issues September 2024 'Inside View'
MGE Energy Issues September 2024 'Inside View'
MGE Energy, Inc. (Nasdaq: MGEE), highlights 49 consecutive years of dividend increases in its investor newsletter, Inside View, which also includes the following topics:
- MGE expanding its use of agrivoltaics through livestock grazing at its newest solar facility.
- Partners seeking regulatory approval for a first of its kind in the U.S. long duration energy storage project.
The newsletter is available on MGE Energy's website at:
http://www.mgeenergy.com/insideview
Inside View is published periodically to provide investors with information about MGE Energy and its primary subsidiary, Madison Gas and Electric.
About MGE Energy
MGE Energy is an investor-owned public utility holding company headquartered in the state capital of Madison, Wis. It is the parent company of Madison Gas and Electric, which generates and distributes electricity in Dane County, Wis., and purchases and distributes natural gas in seven south-central and western Wisconsin counties. MGE Energy's assets total approximately $2.7 billion, and its 2023 revenues were approximately $691 million.
Investor Relations Contact
Ken Frassetto
Director Shareholder Services and Treasury Management
608-252-4723 | kfrassetto@mge.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240913408125/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk